Announced Fri, 24 Jul · 14:15 IST
Dr. Lal PathLabs Q1 FY27 earnings presentation - revenue up 19 percent, PAT up 27 percent
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.7%1-day move
₹1690.10
prior close
₹1729.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.0-0.8-0.9+7.7—————————
Up moveDown movePending
AI summary
Dr. Lal PathLabs shared Q1 FY27 earnings presentation. Revenue grew 19.1 percent YoY to Rs 798 Cr, the highest quarterly growth in 4 years. EBITDA rose 28.7 percent to Rs 247 Cr with margins expanding to 31 percent from 28.7 percent. PAT grew 27.2 percent to Rs 170 Cr. Sample volumes up 10.7 percent, patients up 8.2 percent. Management highlighted healthy cash position for inorganic growth opportunities.
Likely market impact
Strong quarter with margin expansion and highest growth in 4 years signals healthy business momentum and supports inorganic growth optionality.